News

About us

News

Draupnir Holdings Ltd have officially merged with Nordic Group B.V
- by admin

We are pleased to announce that as of January 2023, Draupnir Holdings Ltd which incorporates Altacor, ParaPharm Development & Transdermal…

Company news
We are pleased to announce that as of January 2023, Draupnir...
Nordic Pharma files submission to health Canada for the marketing authorization of methotrexate autoinjector for treating rheumatoid arthritis in Canada
- by admin

Canada, March 29, 2022 – NORDIC PHARMA, a SEVER Life Sciences company, announced today the submission of a New Drug…

Nordic Pharma has acquired ALTIM® (cortivazol) pre-filled syringe to strengthen their Rheumatology portfolio
- by admin

Paris, January 2022 – Nordic Pharma is pleased to announce that they have entered into an agreement with SANOFI to…

Product acquisition
Paris, January 2022 – Nordic Pharma is pleased to announce that...
European Commission approves Teysuno in metastatic colorectal cancer
- by admin

Nordic Pharma announces that on the 24th of January, the European Commission (EC) approved the new indication for Teysuno® (tegafur/gimeracil/oteracil)…

Company news
Nordic Pharma announces that on the 24th of January, the European...
Positive EMA opinion for the use of Teysuno in metastatic colorectal cancer
- by admin

Nordic Pharma has announced that on 16 December 2021, the Committee for Medicinal Products for Human Use (CHMP) adopted a…

Company news
Nordic Pharma has announced that on 16 December 2021, the Committee...
Nordic Pharma present at CPhI !
- by admin

Nordic Pharma will be attending CPhI Worldwide in Milan, Italy from November 9th-11th 2021. We are actively looking for late stage partnering…

Company news
Nordic Pharma will be attending CPhI Worldwide in Milan, Italy from November 9th-11th...
Nordixate® Methotrexate Pre-filled Syringe approved in Colombia
- by admin

Nordic Pharma AAP is pleased to announce that the Nordixate® Methotrexate Pre-filled Syringe has been issued market authorization by Instituto…

Product launch
Nordic Pharma AAP is pleased to announce that the Nordixate® Methotrexate...
New Headquarters Offices
- by admin

Both of Nordic Pharma HQs, located in France and in the Netherlands, have recently moved. Nordic Pharma HQ NL has…

Company news
Both of Nordic Pharma HQs, located in France and in the...
Nordimet® PFS and Pen are launched in Chile!
- by admin

Nordic Pharma Americas, Asia, Pacific are pleased to announce that as of the 15th of April, Nordimet® PFS and Pen are…

Product launch
Nordic Pharma Americas, Asia, Pacific are pleased to announce that as...

About Our Portfolio